Viewing Study NCT07225959


Ignite Creation Date: 2025-12-24 @ 2:55 PM
Ignite Modification Date: 2025-12-29 @ 5:52 PM
Study NCT ID: NCT07225959
Status: RECRUITING
Last Update Posted: 2025-12-15
First Post: 2025-11-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety, Pharmacokinetics, and Occurrence of Anti-Drug Antibodies Following Annual Doses of CD388
Sponsor: Cidara Therapeutics Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-10-29
Start Date Type: ACTUAL
Primary Completion Date: 2027-07
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-07
Completion Date Type: ESTIMATED
First Submit Date: 2025-11-06
First Submit QC Date: None
Study First Post Date: 2025-11-07
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-08
Last Update Post Date: 2025-12-15
Last Update Post Date Type: ESTIMATED